Increased survivability of coronavirus and H1N1 influenza virus under electrostatic aerosol-to-hydrosol sampling

被引:24
|
作者
Piri, Amin [1 ]
Kim, Hyeong Rae [1 ]
Park, Dae Hoon [1 ]
Hwang, Jungho [1 ]
机构
[1] Yonsei Univ, Dept Mech Engn, Seoul 120749, South Korea
关键词
Bio-aerosol; Electrostatic sampler; Polymerase chain reaction; Coronavirus; Ascorbic acid; PERFORMANCE; OXIDATION;
D O I
10.1016/j.jhazmat.2021.125417
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Airborne virus susceptibility is an underlying cause of severe respiratory diseases, raising pandemic alerts worldwide. Following the first reports of the novel severe acute respiratory syndrome coronavirus-2 in 2019 and its rapid spread worldwide and the outbreak of a new highly variable strain of influenza A virus (H1N1) in 2009, developing quick, accurate monitoring and diagnostic approaches for emerging infections is considered critical. Efficient air sampling of coronaviruses and the H1N1 virus allows swift, real-time identification, triggering early adjuvant interventions. Electrostatic precipitation is an efficient method for sampling bio-aerosols as hydrosols; however, sampling conditions critically impact this method. Corona discharge ionizes surrounding air, generating reactive oxygen species (ROS), which may impair virus structural components, leading to RNA and/or protein damage and preventing virus detection. Herein, ascorbic acid (AA) dissolved in phosphate-buffered saline (PBS) was used as the sampling solution of an electrostatic sampler to counteract virus particle impairment, increasing virus survivability throughout sampling. The findings of this study indicate that the use of PBS+AA is effective in reducing the ROS damage of viral RNA by 95%, viral protein by 45% and virus yield by 60%.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Laboratory diagnosis of 2009 H1N1 influenza A virus
    Boggild, Andrea K.
    McGeer, Allison J.
    CRITICAL CARE MEDICINE, 2010, 38 : E38 - E42
  • [42] Management of H1N1 influenza virus respiratory syndrome
    De Rosa, F. G.
    Montrucchio, C.
    Di Perri, G.
    MINERVA ANESTESIOLOGICA, 2009, 75 (11) : 654 - 660
  • [43] INFLUENZA A (H1N1) VIRUS COMPLICATED WITH BACTERIA INFECTION
    Yan, X-X
    Xu, H-B
    Liu, Y.
    Qu, F-F
    Yu, H-M
    Wang, Y-F
    Li, Y-Y
    Liu, D-C
    RESPIROLOGY, 2011, 16 : 60 - 60
  • [44] Severe Influenza A Virus (H1N1) Infection in Pregnancy
    Brown, Cathleen M.
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (02): : 412 - 414
  • [45] Molecular Anatomy of 2009 Influenza Virus A (H1N1)
    Arias, Carlos F.
    Escalera-Zamudio, Marina
    de los Dolores Soto-Del Rio, Maria
    Georgina Cobian-Guemes, Ana
    Isa, Pavel
    Lopez, Susana
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (08) : 643 - 654
  • [46] Pandemic flu A/H1N1 influenza virus: the basics
    Watts, Geoff
    BRITISH MEDICAL JOURNAL, 2009, 339 : b3046
  • [47] Phylogenetic analysis of pandemic influenza A/H1N1 virus
    Arunachalam, Ramaiah
    Paulkumar, Kanniah
    Annadurai, Gurusamy
    BIOLOGIA, 2012, 67 (01) : 14 - 31
  • [48] INFLUENZA-A EPIDEMIC CAUSED BY H1N1 VIRUS
    MEIKLEJOHN, G
    GRAVES, P
    EICKHOFF, TC
    I, J
    MILITARY MEDICINE, 1980, 145 (02) : 129 - 131
  • [49] H1N1 influenza virus as a cause of peripartum cardiomyopathy
    de la Hoz Suarez, Julia
    Cabezas Palacios, M. Nieves
    Novo Cabrera, Juan
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2019, 178 (05) : 335 - 339
  • [50] Oligosaccharide specificity of influenza H1N1 virus neuraminidases
    Mochalova, L.
    Kurova, V.
    Shtyrya, Y.
    Korchagina, E.
    Gambaryan, A.
    Belyanchikov, I.
    Bovin, N.
    ARCHIVES OF VIROLOGY, 2007, 152 (11) : 2047 - 2057